About Nuage Therapeutics
Nuage Therapeutics is a company based in Barcelona (Spain) founded in 2021 by Judit Anido Folgueira, Mateusz Biesaga, Denes Hnisz, and Xavier Salvatella.. Nuage Therapeutics has raised $13.1 million across 1 funding round from investors including Sofinnova Partners and Asabys Partners. Nuage Therapeutics offers products and services including Disordered Protein Therapies. Nuage Therapeutics operates in a competitive market with competitors including Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nymox Pharmaceutical and Glycomantra, among others.
- Headquarter Barcelona, Spain
- Founders Judit Anido Folgueira, Mateusz Biesaga, Denes Hnisz, Xavier Salvatella
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.1 M (USD)
in 1 rounds
-
Latest Funding Round
$13.1 M (USD), Seed
Jun 21, 2023
-
Investors
Sofinnova Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nuage Therapeutics
Nuage Therapeutics offers a comprehensive portfolio of products and services, including Disordered Protein Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative treatments targeting disordered proteins for cancer and diseases
Funding Insights of Nuage Therapeutics
Nuage Therapeutics has successfully raised a total of $13.1M through 1 strategic funding round. The most recent funding activity was a Seed round of $13.1 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $13.1M
-
First Round
First Round
(21 Jun 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Seed - Nuage Therapeutics | Valuation | Sofinnova Partners , Asabys Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nuage Therapeutics
Nuage Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Sofinnova Partners and Asabys Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nuage Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nuage Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nuage Therapeutics Comparisons
Competitors of Nuage Therapeutics
Nuage Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nymox Pharmaceutical and Glycomantra, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops small molecule based drug for multiple disease treatment
|
|
| domain | founded_year | HQ Location |
Cancer therapeutics are developed using dual-targeted radionuclide therapy.
|
|
| domain | founded_year | HQ Location |
Provides research and development of novel drugs and diagnostic products for the aging population
|
|
| domain | founded_year | HQ Location |
Translational glycobiology research on galectin-3 inhibitors is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nuage Therapeutics
When was Nuage Therapeutics founded?
Nuage Therapeutics was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Nuage Therapeutics located?
Nuage Therapeutics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of Nuage Therapeutics?
Judit Anido Folgueira is the current CEO of Nuage Therapeutics. They have also founded this company.
Is Nuage Therapeutics a funded company?
Nuage Therapeutics is a funded company, having raised a total of $13.1M across 1 funding round to date. The company's 1st funding round was a Seed of $13.1M, raised on Jun 21, 2023.
What does Nuage Therapeutics do?
Nuage Therapeutics was founded in 2021 in Barcelona, Spain, within the biotechnology sector. Drug screening assays are developed to address intrinsically disordered proteins involved in biomolecular condensation. Treatments for castration-resistant prostate cancer are targeted through these efforts. Operations focus on innovative drug discovery methods, with a team of co-founders leading research and development activities in Europe.
Who are the top competitors of Nuage Therapeutics?
Nuage Therapeutics's top competitors include Radionetics, Convergent Therapeutics and Emtora Biosciences.
What products or services does Nuage Therapeutics offer?
Nuage Therapeutics offers Disordered Protein Therapies.
Who are Nuage Therapeutics's investors?
Nuage Therapeutics has 2 investors. Key investors include Sofinnova Partners, and Asabys Partners.